致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 Human EphA3 Antibody (Ifabotuzumab, Research Use)
目录号 NBR-0670
别名 HEK4; TYRO4; ETK1
外观 Transparent Liquid
分子量 150kDa
CAS N/A
溶解度 Water, PBS, TBS Buffer,etc.
存储条件 Temp. -80℃
保存时间 see COA
备注1 CHO Expressed
备注2 Ab. Isotype - IgG
目录号 规格 价格 库存状态  
NBR-0670-100UG 100ug ¥550 请咨询
NBR-0670-1MG 1mg ¥3500 请咨询
NBR-0670-5MG 5mg ¥7500 请咨询



【产品概况】
产品名称:Human EphA3 Antibody (Ifabotuzumab, Research Use)
产品编号:NBR-0670
针对靶点:EphA3
抗体药商品名:Ifabotuzumab
抗体药描述:Ifabotuzumab (formerly KB004) is a first-in-class therapeutic non-fucosylated IgG1 (human f-allotype) monoclonal antibody being developed by Humanigen (formerly KaloBios Pharmaceuticals) for the treatment of cancer. The drug was licensed from the Ludwig Institute for Cancer Research.

【产品参数】
产品外观:Transparent Liquid
分子量:~150kDa
CAS:N/A
溶解度:Water; PBS, TBS Buffer等
表达系统:CHO Expressed
抗体亚型:Ab. Isotype - IgG

 
【基因信息】
Gene Name: EphA3
Synonyms: HEK4; TYRO4; ETK1
Target Description: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells.
Ensembl: ENSG00000044524
Uniprot: P29320
 
相关产品